Sarcoma subtypes were also broadly similar to immunotherapy responsive cancers in regard to the trends observed for Treg, CD4-effector, B cell, and NK cell estimates between hot and cold tumors (Supplementary Figure S4). This evidence concerns the gene CD4 and cancer.